AU2001280004A1 - Substituted phthalides as anti-convulsive drugs - Google Patents

Substituted phthalides as anti-convulsive drugs

Info

Publication number
AU2001280004A1
AU2001280004A1 AU2001280004A AU8000401A AU2001280004A1 AU 2001280004 A1 AU2001280004 A1 AU 2001280004A1 AU 2001280004 A AU2001280004 A AU 2001280004A AU 8000401 A AU8000401 A AU 8000401A AU 2001280004 A1 AU2001280004 A1 AU 2001280004A1
Authority
AU
Australia
Prior art keywords
formula
compound
compounds
defined hereinbefore
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280004A
Other languages
English (en)
Inventor
Feng-ming CHU
Zong-Ru Guo
Pierre Lestage
Xinyi Niu
Zhihong Ren
Pierre Renard
Bailing Xu
Guangzhong Yang
Juntian Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Materia Medica of CAMS
Laboratoires Servier SAS
Original Assignee
Institute of Materia Medica of CAMS
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Materia Medica of CAMS, Laboratoires Servier SAS filed Critical Institute of Materia Medica of CAMS
Publication of AU2001280004A1 publication Critical patent/AU2001280004A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
AU2001280004A 2000-06-28 2001-06-27 Substituted phthalides as anti-convulsive drugs Abandoned AU2001280004A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB001193295A CN1182127C (zh) 2000-06-28 2000-06-28 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
CN00119329.5 2000-06-28
PCT/IB2001/001535 WO2002000638A2 (en) 2000-06-28 2001-06-27 Substituted phthalides as anti-convulsive drugs

Publications (1)

Publication Number Publication Date
AU2001280004A1 true AU2001280004A1 (en) 2002-01-08

Family

ID=4587601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280004A Abandoned AU2001280004A1 (en) 2000-06-28 2001-06-27 Substituted phthalides as anti-convulsive drugs

Country Status (19)

Country Link
US (1) US6689808B2 (es)
EP (1) EP1320528A2 (es)
JP (1) JP2004501909A (es)
KR (1) KR20030024710A (es)
CN (2) CN1182127C (es)
AR (1) AR030239A1 (es)
AU (1) AU2001280004A1 (es)
BR (1) BR0112043A (es)
CA (1) CA2413752A1 (es)
CZ (1) CZ2003245A3 (es)
EA (1) EA200300044A1 (es)
HU (1) HUP0301567A3 (es)
MX (1) MXPA02012569A (es)
NO (1) NO20026154L (es)
NZ (1) NZ523174A (es)
PL (1) PL359373A1 (es)
SK (1) SK1062003A3 (es)
WO (1) WO2002000638A2 (es)
ZA (1) ZA200210004B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327639T3 (es) 2003-05-14 2009-11-02 Dsm Ip Assets B.V. Uso de derivados de ftalida para el tratamiento y prevecion de diabetes mellitus.
KR20060121887A (ko) 2003-09-23 2006-11-29 디에스엠 아이피 어셋츠 비.브이. 진성 당뇨병의 치료 및 예방용 조성물
CN1605336A (zh) * 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
US8552058B2 (en) * 2004-06-18 2013-10-08 CSPC Zhongqi Pharmaceutical Technology (Shijazhuang) Co., Ltd. Application of L-n-butylphthalide in preventing and treating dementia
CN106074497A (zh) * 2010-01-13 2016-11-09 石药集团恩必普药业有限公司 丁苯酞及其衍生物在制备治疗帕金森病的药物中的应用
CN102260233A (zh) * 2011-05-04 2011-11-30 武汉科技大学 3-丁基-1(3h)-异苯并呋喃酮衍生物及其制备方法
CN105367526B (zh) * 2015-10-14 2017-07-28 济南诚汇双达化工有限公司 一种高纯度正丁基苯酞的制备方法
CN108727352B (zh) * 2017-04-14 2021-04-23 四川大学 一类哌啶烷氨甲酰基苯酞类化合物、其制备方法和用途
ES2927538T3 (es) * 2018-03-19 2022-11-08 Henan Genuine Biotech Co Ltd Compuestos de ácido benzoico y método de preparación de los mismos y aplicaciones de los mismos
CN108752300B (zh) * 2018-05-16 2022-03-25 中国科学院昆明植物研究所 苄烯叉苯肽类化合物及其药物组合物和其应用
CN109111415B (zh) * 2018-10-25 2022-08-23 安徽中医药大学 一类石斛生物碱衍生物、制备方法和医药用途
CN112010827A (zh) * 2019-05-28 2020-12-01 四川大学 一类苄胺基苯酞类化合物、其制备方法和用途
CN112010837B (zh) * 2019-05-28 2021-12-17 四川大学 一类吡啶甲胺基苯酞类化合物、其制备方法和用途
CN110452203B (zh) * 2019-08-29 2021-04-13 忻州师范学院 一种1-氧代-1,3-二氢-3-羟基苯并呋喃-5-甲酸的制备方法
CN112794831B (zh) * 2021-04-06 2021-07-27 北京理工大学 3-(3′-羟基丁基)异苯并呋喃-1(3h)-酮衍生物及其组合物、制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183053B (it) * 1984-02-02 1987-10-05 Farmaceutico Ct Lab Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
JPH02209861A (ja) * 1988-05-06 1990-08-21 Ono Pharmaceut Co Ltd アミノ酸誘導体及び該誘導体を有効成分として含有するエンケファリナーゼ阻害剤
TW270133B (es) * 1993-09-17 1996-02-11 Ciba Geigy
DE19618854A1 (de) * 1996-05-10 1997-11-13 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden

Also Published As

Publication number Publication date
NO20026154D0 (no) 2002-12-20
US6689808B2 (en) 2004-02-10
AR030239A1 (es) 2003-08-13
CA2413752A1 (en) 2002-01-03
HUP0301567A3 (en) 2005-08-29
WO2002000638A8 (en) 2003-08-28
MXPA02012569A (es) 2004-05-17
EA200300044A1 (ru) 2003-06-26
SK1062003A3 (en) 2003-05-02
NO20026154L (no) 2003-02-20
CN100402515C (zh) 2008-07-16
EP1320528A2 (en) 2003-06-25
HUP0301567A2 (hu) 2003-09-29
BR0112043A (pt) 2003-10-28
CN1440398A (zh) 2003-09-03
NZ523174A (en) 2004-06-25
JP2004501909A (ja) 2004-01-22
US20030220393A1 (en) 2003-11-27
CZ2003245A3 (cs) 2003-05-14
CN1182127C (zh) 2004-12-29
WO2002000638A3 (en) 2002-05-23
PL359373A1 (en) 2004-08-23
CN1330069A (zh) 2002-01-09
WO2002000638A2 (en) 2002-01-03
ZA200210004B (en) 2003-12-10
KR20030024710A (ko) 2003-03-26

Similar Documents

Publication Publication Date Title
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
US5604261A (en) Arylalkyl (thio)amides
US6689808B2 (en) Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
CZ304702B6 (cs) (4R) a (4S) diastereoizomery (2S)-2-[2-oxo-4-propylpyrrolidinyl] butanamidu, farmaceutická kompozice s jejich obsahem a jejich použití
RU1779251C (ru) Способ получени 1-(4-аминофенил)-4-метил-7,8-метилендиокси-3,4-дигидро-5Н-2,3-бензодиазепина или его кислотно-аддитивных солей
JPS60255764A (ja) （ｒ）‐アルフア‐エチル‐２‐オキソ‐１‐ピリジンアセトアミド及びその製法並びに該化合物を含有する製薬組成物
HU191161B (en) Process for production of derivatives of tieno /2,2-a/ piramidin and their salts
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
JPH0660138B2 (ja) ジ−及びテトラ−ヒドロナフタレン類，その製法及びそれを含む医薬組成物
JP2544183B2 (ja) 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
CZ199992A3 (en) 2-(piperidin-1-yl)ethanol derivatives, process of their preparation and pharmaceutical compositions containing said derivatives
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
AU2114600A (en) Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
EP0118564B1 (en) 4-amino-tetrahydro-2-naphthoic acid derivatives
WO2003039439A2 (de) Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel
AU649302B2 (en) Tricyclic pyridone derivative
US3951985A (en) Lactams and process for their manufacture
US4578397A (en) Indeno(1,2-b)pyrrole derivatives
CA2004643A1 (fr) Derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4067985A (en) Lactum drug compositions
DD260068A5 (de) Verfahren zur herstellung von 5- oder 6-substituierten-beta-carbolin-3-carbonsaeureestern
FR2807754A1 (fr) Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU192236B (en) Process for producing 4,5,6,7-tetrahydrofuro- or -1h-pyrrolo/2,3-c/pyridine derivatives and pharmaceutical compositions containing them
HU198932B (en) Process for producing tetracyclic quinazolinones and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application